Filtros de búsqueda

Lista de obras de Roberta A Diotti

A Biologically-validated HCV E1E2 Heterodimer Structural Model

artículo científico publicado en 2017

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

artículo científico publicado en 2012

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

artículo científico publicado en 2019

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.

artículo científico publicado en 2012

Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study

artículo científico publicado en 2017

Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects

artículo científico publicado en 2019

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

artículo científico publicado en 2015

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy

artículo científico publicado en 2014

Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro

artículo científico publicado en 2020

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.

artículo científico publicado en 2016

Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

artículo científico publicado en 2017

HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role

artículo científico

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

artículo científico publicado en 2009

Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia

artículo científico publicado en 2008

Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein

artículo científico publicado en 2008

Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection

scientific article published on 19 June 2020

JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?

artículo científico publicado en 2013

Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).

artículo científico publicado en 2009

Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies

artículo científico publicado en 2008

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

artículo científico publicado en 2010

Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.

artículo científico publicado en 2012

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?

artículo científico publicado en 2012

New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.

artículo científico publicado en 2017

New therapeutic options for HCV infection in the monoclonal antibody era

artículo científico publicado en 2012

Next Generation Vaccines for Infectious Diseases.

artículo científico publicado en 2019

Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda